Edgar Servin-Montes

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12.

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12.

Journal: Frontiers in genetics

Published: January 27, 2022

Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.

Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.

Journal: Bosnian journal of basic medical sciences

Published: January 20, 2022

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.

Journal: Cancer biomarkers : section A of Disease markers

Published: May 31, 2021

Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.

Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.

Journal: Archives of gynecology and obstetrics

Published: March 20, 2020

Experiencia con el uso de olaparib en pacientes con cáncer de ovario.

Experiencia con el uso de olaparib en pacientes con cáncer de ovario.

Journal: Gaceta medica de Mexico

Published: December 03, 2019

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.

Journal: Translational oncology

Published: September 12, 2019

Interplay between immune cells in lung cancer: beyond T lymphocytes.

Interplay between immune cells in lung cancer: beyond T lymphocytes.

Journal: Translational lung cancer research

Published: February 02, 2019

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: September 14, 2017

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients.

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients.

Journal: Oncotarget

Published: August 06, 2017

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients.

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients.

Journal: British journal of cancer

Published: April 03, 2017

Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.

Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.

Journal: Life sciences

Published: August 11, 2016

Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.

Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 04, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026